Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review

Long-term remission in schizophrenia and related psychoses with long-acting risperidone: Results obtained in an open-label study with an observation period of 18 months

(2011) P.-M. Llorca et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Partial Compliance With Antipsychotic Medication is Common in Patients With Schizophrenia

(2009) Christine Rummel-Kluge et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Oral versus injectable antipsychotic treatment in early psychosis: Post hoc comparison of two studies

(2009) Robin Emsley et al.   CLINICAL THERAPEUTICS

Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry

(2009) J. M. Olivares et al.   CURRENT MEDICAL RESEARCH AND OPINION

P03-05 Weight gain and hyperprolactinemia in schizophrenic patients treated during twelve months with long acting risperidone

(2009) F. Duarte Garcia et al.   EUROPEAN PSYCHIATRY

P03-21 Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable versus quetiapine: Randomized, long-term, open-label, clinical trial results (ConstaTRE)

(2009) W. Gaebel et al.   EUROPEAN PSYCHIATRY

P03-26 Survey of safety and efficacy of long-acting injectable risperidone in daily practice: An open-label, non-interventional prospective study

(2009) E. Parellada et al.   EUROPEAN PSYCHIATRY

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)

(2009) J.M. Olivares et al.   EUROPEAN PSYCHIATRY

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Comparison of treatment completion rates for olanzapine pamoate and risperidone microspheres

(2009) K. S. Akhras et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Risperidone Long-Acting Injection

(2009) David M. Taylor et al.   JOURNAL OF CLINICAL PSYCHIATRY

An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia

(2009) John Lauriello et al.   JOURNAL OF CLINICAL PSYCHIATRY

Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder

(2009) Diana O. Perkins et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Cross-Sectional Study of Patients' Perspectives on Adherence to Antipsychotic Medication

(2009) Maxine X. Patel et al.   JOURNAL OF CLINICAL PSYCHIATRY

Long-Acting Injectable Risperidone in the Treatment of Subjects With Recent-Onset Psychosis

(2009) Robin Emsley et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Risk profiles for non-adherence to antipsychotic medications

(2008) T. V. MCCANN et al.   Journal of Psychiatric and Mental Health Nursing

Depot and oral antipsychotics: patient preferences and attitudes are not the same thing

(2008) MX Patel et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Long-acting risperidone improves negative symptoms in stable psychotic patients

(2008) VA Curtis et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effectiveness of risperidone long-acting injection in first-episode schizophrenia: In naturalistic setting

(2008) Borah Kim et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Partial compliance in schizophrenia and the impact on patient outcomes

(2008) Pierre-Michel Llorca   PSYCHIATRY RESEARCH

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia

(2008) Rajiv Tandon et al.   SCHIZOPHRENIA RESEARCH

Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS®) and its relationship to sociodemographic, clinical and psychopathological variables

(2008) Francisco J. Acosta et al.   SCHIZOPHRENIA RESEARCH

Tactics and technologies to manage nonadherence in patients with schizophrenia

(2008) William M. Glazer et al.   Current Psychiatry Reports